Skip to content

DMK PHARMACEUTICALS CORPORATION: filings

Every DMK PHARMACEUTICALS CORPORATION annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filing record ends 2023-11-14

The latest filing in this captured record is a 10-Q filed 2023-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. DMK PHARMACEUTICALS CORPORATION may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-14fiscal Q3 2023401050001999371-23-000197
10-Q2023-08-21fiscal Q2 2023391040001387131-23-009990
10-Q2023-05-15fiscal Q1 202338770001387131-23-006540
10-K2023-03-16fiscal FY 202243860001387131-23-003523
10-Q2022-11-14fiscal Q3 2022431190001387131-22-011400
10-Q2022-08-10fiscal Q2 2022421120001387131-22-008584
10-Q2022-05-16fiscal Q1 202240810001387131-22-006207
10-K2022-03-31fiscal FY 202141850001387131-22-004483
10-Q2021-11-22fiscal Q2 2021501350001387131-21-011421
10-Q2021-11-22fiscal Q1 2021481000001387131-21-011411
10-Q2021-11-22fiscal Q3 2021391040001387131-21-011405
10-K2021-04-15fiscal FY 2020541320001387131-21-004529
10-Q2020-11-09fiscal Q3 2020471230001387131-20-009722
10-Q2020-08-17fiscal Q2 2020491270001387131-20-007644
10-Q2020-05-18fiscal Q1 202046940001387131-20-004946
10-K2020-03-30fiscal FY 2019521050001387131-20-003438
10-Q2019-11-12fiscal Q3 2019461180001387131-19-008553
10-Q2019-08-08fiscal Q2 2019431120001387131-19-005888
10-Q2019-05-09fiscal Q1 201943870001387131-19-003481
10-K2019-03-15fiscal FY 201848970001387131-19-001966
10-Q2018-11-09fiscal Q3 2018411010001387131-18-006055
10-Q2018-08-09fiscal Q2 2018411000001387131-18-003822
10-Q2018-05-10fiscal Q1 201839790001387131-18-002009
10-K2018-03-16fiscal FY 201745930001387131-18-001080
10-Q2017-11-14fiscal Q3 201739910001387131-17-005528
10-Q2017-08-14fiscal Q2 201734780001387131-17-004179
10-Q2017-05-12fiscal Q1 201733550001387131-17-002691
10-K2017-03-30fiscal FY 201643760001387131-17-001745
10-Q2016-11-14fiscal Q3 201639900001387131-16-007979
10-Q2016-08-15fiscal Q2 201638870001387131-16-006612
10-Q2016-05-13fiscal Q1 201627520001387131-16-005504
10-K2016-03-23fiscal FY 201532730001387131-16-004688
10-Q2015-11-09fiscal Q3 201527730001387131-15-003213
10-Q2015-08-07fiscal Q2 201527740001564590-15-006674
10-Q2015-05-14fiscal Q1 201528540001564590-15-004315
10-Q2014-11-14fiscal Q2 201425600001387131-14-003804
10-Q2014-08-13fiscal Q1 201423460001387131-14-002913
10-K2014-06-23fiscal FY 201433600001387131-14-002262
10-Q2014-02-14fiscal Q3 201323540001387131-14-000542
10-Q2013-11-13fiscal Q2 201320500001387131-13-004242
10-Q2013-08-19fiscal Q1 201319370001387131-13-003094
10-K2013-07-03fiscal FY 201223450001387131-13-002469
10-Q2013-02-19fiscal Q3 201222550001387131-13-000496
10-Q2012-11-13fiscal Q2 201221560001387131-12-003643
10-Q/A2012-08-17fiscal Q1 201222450001387131-12-002827
10-K2012-06-29fiscal FY 201127510001387131-12-002016
10-Q2012-02-14fiscal Q3 201126570001387131-12-000314
10-Q2011-11-21fiscal Q2 201127610001387131-11-002673
10-Q2011-08-15fiscal Q1 201124450001387131-11-001707

Inspect the source

Entity
DMK PHARMACEUTICALS CORPORATION / CIK 0000887247
Captured
SEC response SHA-256
cc88d438258619b3d6acde0c3ef806d208e463a48f69c1a0310fac7d087cb187

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000887247.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))